Both homocysteine and high-sensitivity C-reactive protein (hs-CRP) are biomarkers of systemic risk, particularly in relation to cardiovascular health, inflammation, and the biology of ageing.
What is homocysteine?
Homocysteine is an amino acid that exists temporarily in the body during the methylation cycle. It is not a substance the body needs to accumulate; rather, it is an intermediate that must be quickly processed and kept in balance.
Where does homocysteine come from?
It is produced from the metabolism of methionine (derived from dietary protein).
Simplified pathway:
• Methionine → SAMe → SAH → Homocysteine
The body must then either eliminate or recycle homocysteine.
How is homocysteine processed?
- Recycled back into methionine
Requires vitamin B12 and vitamin B9 (folate) - Converted into antioxidants
Used to produce glutathione (a key antioxidant), requiring vitamin B6
What does homocysteine indicate?
Homocysteine is associated with:
- Methylation cycle function
A crucial biological cycle responsible for methyl group (-CH₃) transfer, affecting gene regulation, brain function, and detoxification
→ High homocysteine suggests impaired methylation - Cardiovascular risk
- Vitamin status (B6, B12, folate)
If homocysteine is elevated (hyperhomocysteinaemia):
It is linked to increased risk of:
- Cardiovascular disease
- Stroke and coronary artery disease (CAD)
- Vascular inflammation
- Accelerated ageing
- Vitamin B deficiency (B12, B6, B9)
- Impaired methylation
- Cognitive decline
Typical reference ranges (µmol/L):
- < 10 : Optimal
- 10–15 : Borderline
- > 15 : High
- ≥ 30 : Very high (hyperhomocysteinaemia)
How to lower homocysteine:
- Supplement or consume vitamins B12, B6, and B9 (folate)
- Eat leafy green vegetables (rich in folate)
- Reduce alcohol intake
What does hs-CRP indicate?
High-sensitivity C-reactive protein (hs-CRP) is a marker of low-grade, chronic systemic inflammation.
hs-CRP levels (mg/L):
- < 1.0 : Low risk
- 1.0–3.0 : Moderate risk
- > 3.0 : High risk
- ≥ 10 : Suggestive of acute infection
What does a high hs-CRP mean?
- Chronic low-grade inflammation
- Increased cardiovascular risk
- Associated with metabolic syndrome
- Linked to visceral fat and insulin resistance
- Reflects age-related inflammatory burden (inflammaging)
Interpreting both markers together:
- High homocysteine + normal hs-CRP
→ Possible methylation or B vitamin issue - Normal homocysteine + high hs-CRP
→ Chronic inflammation - Both elevated
→ High vascular and inflammatory risk - Both low
→ Generally normal status
Within a Longevity Framework, assess alongside:
- Vitamin B12
- Vitamin B9 (folate)
- Lipid profile (cholesterol, triglycerides, HDL, LDL)
- Ferritin
- HbA1c
- Omega-3 index
- Kidney function (BUN, creatinine, eGFR)
→ Elevated homocysteine may be linked to declining kidney function
→ Elevated hs-CRP is often seen in obesity
Summary
- Homocysteine is a marker of methylation efficiency and endothelial (vascular lining) health
- hs-CRP is a marker of systemic inflammation
When interpreted together, these markers reflect vascular ageing and the cumulative inflammatory burden associated with ageing (inflammaging).
References
- Danesh, J., Wheeler, J. G., Hirschfield, G. M., et al. (2004).C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 350(14), 1387–1397.
- Lonn, E., Yusuf, S., Arnold, M. J., et al. (2006).Homocysteine lowering with folic acid and B vitamins in vascular disease. New England Journal of Medicine, 354(15), 1567–1577.
- Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (2000).
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 342(12), 836–843. - Smith, A. D., & Refsum, H. (2021).Homocysteine – from disease biomarker to disease prevention. Journal of Internal Medicine, 290(4), 826–854.
- Yan, J., Wang, D., et al. (2010).Elevated homocysteine and C-reactive protein levels are associated with increased risk of cardiovascular and cerebrovascular events. Journal of Huazhong University of Science and Technology Medical Sciences, 30(5), 596–601.
